United Health Products, Inc. (UEEC)
- Previous Close
0.1876 - Open
0.1850 - Bid --
- Ask --
- Day's Range
0.1850 - 0.2000 - 52 Week Range
0.1160 - 0.4500 - Volume
10,731 - Avg. Volume
152,696 - Market Cap (intraday)
49.367M - Beta (5Y Monthly) -0.23
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 8, 2024 - May 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, assisted living and nursing homes, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mesquite, Nevada.
uhpcorp.comRecent News: UEEC
Performance Overview: UEEC
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UEEC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UEEC
Valuation Measures
Market Cap
49.37M
Enterprise Value
50.06M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.71k
Price/Book (mrq)
--
Enterprise Value/Revenue
1.73k
Enterprise Value/EBITDA
-20.00
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-477.54%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.62M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
95.42k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.6M